Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
View all videos

AACR 2022

American Association for Cancer Research 2022 Meeting
08–13 April 2022 | New Orleans, LA

🎥Frederik Marmé, MD, PhD, of @HeidelbergU shares promising results of dual checkpoint inhibitors in gynecologic cancers. Notable improvements in response rates for ipilimumab/nivolumab combo:

➡️⬅️

@ASCO @OncoAlert #ASCO24 #ImmunOnc #GyncOnc #GyncSM

Image for twitter card

Emerging therapies in gynecologic oncology at ASCO 2024

Frederik Marmé, MD, PhD, University of Heidelberg, Germany, discusses the results presented from studies investigating ...

ow.ly

Load More

AACR 2022

American Association for Cancer Research 2022 Meeting
08–13 April 2022 | New Orleans, LA
The AACR Annual Meeting is the focal point of the cancer research community, where scientists, clinicians, other health care professionals, survivors, patients, and advocates gather to share the latest advances in cancer science and medicine. From population science and prevention; to cancer biology, translational, and clinical studies; to survivorship and advocacy; the AACR Annual Meeting highlights the work of the best minds in cancer research from institutions all over the world.
View all videos

🎥Frederik Marmé, MD, PhD, of @HeidelbergU shares promising results of dual checkpoint inhibitors in gynecologic cancers. Notable improvements in response rates for ipilimumab/nivolumab combo:

➡️⬅️

@ASCO @OncoAlert #ASCO24 #ImmunOnc #GyncOnc #GyncSM

Image for twitter card

Emerging therapies in gynecologic oncology at ASCO 2024

Frederik Marmé, MD, PhD, University of Heidelberg, Germany, discusses the results presented from studies investigating ...

ow.ly

Load More